The Mild and Rapidly Improving Stroke Study (MaRISS): Rationale and design. Issue 9 (December 2019)
- Record Type:
- Journal Article
- Title:
- The Mild and Rapidly Improving Stroke Study (MaRISS): Rationale and design. Issue 9 (December 2019)
- Main Title:
- The Mild and Rapidly Improving Stroke Study (MaRISS): Rationale and design
- Authors:
- Romano, Jose G
Gardener, Hannah
Campo-Bustillo, Iszet
Khan, Yosef
Riley, Nikesha
Tai, Sofie
Sacco, Ralph L
Khatri, Pooja
Smith, Eric E
Schwamm, Lee H - Abstract:
- Rationale: Although mild and rapidly improving stroke symptoms are the most common first stroke presentation, this group has been understudied in acute stroke trials. Observational and retrospective studies suggest residual disability in one third of patients. Aims: To elucidate long-term outcomes of patients with mild and rapidly improving stroke, evaluate the predictors of outcome, and examine the association with alteplase treatment. Sample size: The initial estimate of 2650 participants to detect a 9% difference in non-disabled 90-day outcomes between alteplase-treated and untreated participants was revised to 2000 after a pre-planned re-estimation based on actual treatment rates. Methods and design: Prospective observational study of patients with mild ischemic stroke (NIHSS ≤ 5) or rapidly improving stroke symptoms evaluated within 4.5 h from onset. Outcomes: The primary outcome is the proportion of patients with modified Rankin Scale (mRS) ≥ 2 at 90 days; the primary safety outcome is symptomatic hemorrhagic transformation within 36 h among those treated with alteplase. Secondary outcomes include the 90-day Barthel Index, Stroke Impact Scale 16, European Quality of Life scale, mRS at 30 days, and 30- and 90-day mortality. Discussion: MaRISS will define outcomes and their predictors and clarify the effects of alteplase in patients with mild and rapidly improving stroke symptoms, providing clinicians with important information to manage this population.
- Is Part Of:
- International journal of stroke. Volume 14:Issue 9(2019)
- Journal:
- International journal of stroke
- Issue:
- Volume 14:Issue 9(2019)
- Issue Display:
- Volume 14, Issue 9 (2019)
- Year:
- 2019
- Volume:
- 14
- Issue:
- 9
- Issue Sort Value:
- 2019-0014-0009-0000
- Page Start:
- 983
- Page End:
- 986
- Publication Date:
- 2019-12
- Subjects:
- Stroke -- outcome assessment -- tissue plasminogen activator -- research design
616.8005 - Journal URLs:
- http://wso.sagepub.com/ ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ijs ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1177/1747493019873595 ↗
- Languages:
- English
- ISSNs:
- 1747-4930
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.681485
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12006.xml